Processa Share Price

Processa Share Price

NASDAQ: PCSA | Micro Cap | Healthcare
$1.73
-$0.00 (-0.29%) Last updated on 19 Nov, 2026 | 01:00 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Processa Stock Performance

Open
$1.70
Prev. Close
$1.73
Circuit Range
N/A
Day Range
$1.70 - $1.74
Year Range
$0.11 - $8.60
Volume
1,451
Average Traded
$1.72

Processa Share Price Today

As of 19 November 2026, Processa Pharmaceuticals, Inc.'s share price is $1.73. The stock opened at $1.70, compared to its previous close of $1.73. During today's trading session, Processa Pharmaceuticals, Inc.'s share price traded between $1.70 and $1.74, with an average price of $1.72. Over the past 52 weeks, the stock has recorded a high of $8.60 and a low of $0.11. In terms of performance, Processa Pharmaceuticals, Inc.'s share price has declined by 33.65% over the last six months and is up 568.60% on a year-on-year basis.

Processa Share Price Chart

Line chart of the Processa price trend over the selected period. The price fell overall, ranging from 1.70 to 1.77, ending at 1.73.
$1.70$1.74
L
Show Current Price
H

Processa Stock Fundamentals & Key Indicators

Market Cap
$2.26M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-69.15
Revenue (TTM)
$0.00
Return On Equity (TTM)
-107.22%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-5351.19%

Processa Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.36-$3.38-$3.27-$183.16
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-0.60%3.25%-5501.22%

Processa Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$27.42-$11.12-$11.85-$13.56
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A59.45%-6.56%-14.43%

Processa Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.141.350.150.23
Current Assets5.671.885.638.39
Total Assets7.813.235.798.62
Non Current Liabilities0.00.00.070.15
Current Liabilities2.241.530.731.0
Total Liabilities2.241.530.81.15
Shareholders' Equity5.581.74.997.47

Processa Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-11.39-11.25-8.06-9.61
Investing-0.850.00.00.0
Financing16.587.736.27-0.39

Corporate Actions

Split
Ex-date: 17 Dec 2025

Split
Ex-date: 22 Jan 2024

Split
Ex-date: 23 Dec 2019

About Processa

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

Processa Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.85
$1.73
-7.01%
Oct 2026
$1.73
$1.85
+8.48%
Sep 2026
$2.06
$1.71
-18.96%
Aug 2026
$2.10
$2.11
-1.86%
Jul 2026
$1.96
$2.15
+13.46%
Jun 2026
$2.63
$1.90
-27.12%
May 2026
$2.69
$2.60
-5.11%
Apr 2026
$2.69
$2.74
+2.24%
Mar 2026
$2.17
$2.68
+20.18%
Feb 2026
$2.77
$2.23
-28.30%
Jan 2026
$2.95
$3.11
+7.99%
Dec 2025
$0.26
$2.88
+1,016.28%

Processa Share Price FAQs